Hypertrophic Cardiomyopathy: Genes and Mechanisms
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl25714 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Jinli Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, First Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Programme of Gansu Province.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is a hereditary disease of the myocardium characterized by asymmetric hypertrophy (mainly the left ventricle) not caused by pressure or volume load. Most cases of HCM are caused by genetic mutations, particularly in the gene encoding cardiac myosin, such as MYH7, TNNT2, and MYBPC3. These mutations are usually inherited autosomal dominantly. Approximately 30–60% of HCM patients have a family history of similar cases among their immediate relatives. This underscores the significance of genetic factors in the development of HCM. Therefore, we summarized the gene mutation mechanisms associated with the onset of HCM and potential treatment directions. We aim to improve patient outcomes by increasing doctors’ awareness of genetic counseling, early diagnosis, and identification of asymptomatic patients. Additionally, we offer valuable insights for future research directions, as well as for early diagnosis and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Medicine, First Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China.
- Gansu Provincial Clinical Medical Research Center for Geriatric Diseases, 730000 Lanzhou, Gansu, China.
- Department of Anesthesia and Surgery, First Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China.
- The First Clinical Medical College of Lanzhou University, 730000 Lanzhou, Gansu, China.
Förderung
- Key Research and Development Programme of Gansu Province
Zitieren
APA
Chen, J., Xing, Y., Sun, J., Liu, Y., Lang, Z., Zhang, L., & Yang, J. (2025). Hypertrophic Cardiomyopathy: Genes and Mechanisms. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl25714
Vancouver
Chen J, Xing Y, Sun J, Liu Y, Lang Z, Zhang L, et al. Hypertrophic Cardiomyopathy: Genes and Mechanisms. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl25714
BibTeX
@article{Chen2025,
author = {Chen, Jinli and Xing, Yang and Sun, Jie and Liu, Yongming and Lang, Zekun and Zhang, Lei and Yang, Jinggang},
title = {Hypertrophic Cardiomyopathy: Genes and Mechanisms},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl25714}
}
EUVIMED